Company number.. 05498067 Charity Number= 1113263 International Federation of Gynecology and Obstetrics Report and financial statements For the year ended 31 December 2024 SA YER VINCENT International Federatlon of Gynecology and Obstetrlcs Contents For the year ended 31 December 2024 Reference and administrative information Trustees, annual report Independent auditor'5 report Consolidated statement of financial activities .24 Balance sheets .25 Consolidated statement of cash flows........................................................................................... 26 Notes to the financial statements .27 International Federatlon of Gynecology and Obstetrlcs Reference and administrative information For the year ended 31 December 2024 Company number 05498067 Charlty number 1113263 Registered office and operational address FIGO House. Suite 3 Waterloo Court, l O Theed Street. London SEI 8ST Country of reglstratlon England & Wales Country of Incorporatlon United Kingdom Other name that the charltable company uses 'FIGO' Trustees Trustees. who are also directors under company law, who served during the year and up to the date of this report were as follows- Dr. Anne Beatrice Kihara Dr. Edgar Ivan Ortiz Lizcano Prof. Shantha Kumari Sekaran Dr. Ravi Chandran Prof. Frank Louwen Prof. Chiara Benedetto Dr. Ernesto Castelazo Dr. Blami Dao Dr. Nestor Cesar Garello Dr. Hrishikesh Pai President Vice President Honorary Treasurer Honorary Secretary President Elect Regional Trustee Regional Trustee Regional Trustee Regional Trustee Regional Trustee Key management personnel Frances Longley Andrew Wiles Christopher Horry Mark Lywood Mehala Manimohan Chief Executive Chief Operating Officer Director of Finance luntil 28 February 2025) Interim Head of Finance (until 16July 2025) Head of Finance Istarted on 02 June 202 5) Bankers HSBC 431 Oxford St. London Wl C 2DA Solicitors Davies & Partners 57 Queen Anne Street. London Wl G 9JR Hempsons 100 Wood Street. London. EC2V 7AN International Federatlon of Gynecology and Obstetrlcs Reference and administrative information For the year ended 31 December 2024 Auditor Sayer Vincent LLP Chartered Accountants and Statutory Auditor I l O Golden Lane LONDON ECIY OTG International Federatlon of Gynecology and Obstetrlcs Trustees, report For the year ended 31 December 2024 The trustees present their report and the audited financial statements for the year ended 31 December 2024. Reference and administrative information set out on pages l and 2 forms part of this report. The financial statements comply with current statutory requirements, the memorandum and articles of association and the Statement of Recommended Practice - Accounting and Reporting by Charities.. SORP applicable to charities preparing their accounts in accordance with FRS 102. Objectives and activities Purposes and aims The charity's object. for which FIGO is established. is restricted to the promotion of the health, wellbeing and rights of women worldwide by ensuring high standards in the practice of gynaecology and obstetrics for the benefit of the public. The main activities undertaken by the Charlty to further its charitable object for the public benefit include but are not limited to: Projects aimed at improving women's health, wellbeing and rights in low and middle- income countries including safe motherhood projects designed to reduce maternal mortality as well as sexual and reproductive health. The awarding of modest grants to FIGO Committees and National Societies to help in the promotion of the health and wellbeing of women worldwide and to improve the practice of gynecology and obstetrics. The organisation of international workshops and meetings. The production of educational material relating to women's health and the practice of obstetrics and gynaecology. These include webinars. Guidelines and other Best Practice advice. The activities of the subsidiary. FIGO Trading Limited, include but are not limited to.. The organisation of a World Congress of Gynecology and Obstetrics held every two years and regional congresses from time to time. The production of the International Journal of Gynecology & Obstetrics and other FIGO publications. International Federatlon of Gynecology and Obstetrlcs Trustees, report For the year ended 31 December 2024 The Charity is committed to: Encouraging all efforts for raising the status of women and for advancing their role in all issues related to women's health. Promoting sexual and reproductive health and rights and service5 through education, research and advocacy that will support the provision of accessible. efficient. affordable. Sustainable comprehensive reproductive health services. Accelerating its efforts and activities in respect of the United Nations, Sustainable Development Goals (SDG) and to achieving these targets especially in the area of safe motherhood and new-born health and gender equality. Continually upgrading the practice of gynaecology and obstetrics through research implementation. education and training and by maintaining the highest levels of professionalism and scientific and ethical standards. Improving communication with and between Society Member associations and building the capacities of those from low-resource countries through strengthening leadership, management. good practice and the promotion of policy dialogues. Strengthening capacities to enable Society Member associations to play a pivotal role in the development and implementation of sustainable programmes aimed at the improvement of care available to women and new-borns especially for poor and underserved populations. These include developing their abilities to advocate on behalf of women and those who care for them to policy makers at regional and national level. Recognising the importance of collaborative efforts for advancing women's health and right5. the Charity is committed to strengthening partnerships Wlth other international professional organisations, UN agencies, and the public/private sector to achieve its objectives. Public Benefit ststement The trustees have referred to the guidance contained in the Charity Commission's general guidance on public benefit when reviewing the charity's aims and objectives and in planning its future activities. In particular. the trustees consider how planned activities will contribute to the aims and objectives that have been set. The trustees review the aims, objectives and activities of the charity each year. This report looks at what the charity has achieved and the outcomes of its work in the reporting period. The International Federatlon of Gynecology and Obstetrlcs Trustees, report For the year ended 31 December 2024 trustees report the success of each key activity and the benefits the charity has brought to those groups of people that it is set up to help. Achievements and performance The charity's main activities and who it tries to help are described below. All its charitable activities focus on the improvement of wornen's health and reproductive rights, the reduction of disparities in healthcare available to women and new-borns. as well as advancing the science and practice of gynaecology and obstetrics and are undertaken to further FIGO'S charitable purposes for the public benefit. The Charity is the only global organisation that brings together professional societies of obstetricians and gynaecologists from across the world. The Charity currently has Society Member associations in 139 countrieslterritories. Restricted projects The Charity has been fortunate to receive a number of large grants to fund specific multi-year projects. These include projects aimed at improving the health and wellbeing of all women whether pregnant or non-pregnant and the services that support this in low- and middle- resource countrieslterritories. FIGO works with its Member associations to deliver improved health interventions or helps the Member associations build capacity and capability in a particular region or nation. FIGO currently has a number of large project5 in progress and received money to support its activities from donors totalling £2.165.873 during 2024 (2023.. £2.836.221). including £613,317 (2023= £755,859) for the project relating to Advocating Safe Abortion, £290,315 (2023= £610.301) from donors to our Fistula Surgery Training Initiative. £434.940 (2023= £364,484) for our combatting Post-Partum Haemorrhage (PPH) projects, £101 ,457 (2023, nil) for the WHO funded project, Abortion and Contraception Care Together and £724,607 (2023: £1.100.802) for our FIGO Leadership Development Initiative (LDI:REACH) which is being sponsored by the Bill and Melinda Gates Foundation and aims to improve maternal and new- born health outcomes through advocacy and improved care in six countries. These specific restricted projects are normally undertaken only as and when funding becomes available. and a project generally takes place over the term of the grant funding which is typically between one and three years. FIGO always aims to demonstrate positive and sustainable outcomes from its projects in improving maternal health. Evidence of strong outcomes can also help FIGO to secure further grant funding to expand a project's activities to other countries or to reach greater numbers of women and healthcare professionals. Project activities are continuously monitored and evaluated in line with the project objectives and the requirements of the funder. During 2024. projects delivered the following significant achievements: International Federatlon of Gynecology and Obstetrlcs Trustees, report For the year ended 31 December 2024 Advocating for Safe Abortion Project (ASA) The Advocating for Safe Abortion Project5 Started in 2019 with funding from a large anonymous donor which ran through to end of 2023. During this time FIGO worked with 12 members societies in Africa and Latin America, as well as two regional federations Isociété Africaine des Gynecologues et Obstetriciens - SAGO. and the East. Central and Southern African College of Obstetrics and Gynecology - ECSACOG) and associated Communities of Practice. Once this initial grant ended. new funding was provided by FJSI and the Hewlett foundation to continue the work in West Africa. The societies directly involved in the ASA Project during 2024 were Cameroon, Mali, and Burkina Faso. As per the Theo of Chan e, the ASA project continues to be structured around two core pillars. First is the strengthening of organisational and technical capacity of national societies of ObGyn to enable them to become national leaders in Sexual and Reproductive Health (SRHR), driving positive change within their local context. The second is engagement in advocacy for safe abortion via a range of different activities and partnerships. leading to incremental positive changes in safe and quality abortion care through the society's influence on policies, attitudes and knowledge. Building networks and working in partnerships at national and international levels has been a key element. The project also continues to work with SAGO and the 20 country Community of Practice created previously and developed through partnership with other regional partners. A significant achievement in 2024 was the in-person meeting of this Community of Practice held in Togo in September 2024, bringing together over 50 health care providers including ObGyns, midwives and young professionals to discuss matters relating to safe abortion advocacy. The project also had a strong presence at national Congresses in both Togo and Cote d'lvoire. bringing together representatives of FIGO member societies across Francophone Africa to continue discussions on safe abortion in the region. The project also continues to work with FIGO'S Safe Abortion Committee and contributes to raise FIGO'S international profile on the topic of abortion/SRHR. This included representation during the virtual Global Safe Abortion Dialogue in July 2024. Also included under this portfolio was a one year project with the member society in Zambia to implement WHO guidelines pertaining to self-managed abortion, funded through a collaboration with CHAI and CIFF. This project finished mid-2024 with a range of outputs that were shared via FIGO'S website and other channels. Collaborate for Women: Abortion and Contraception Care Together (A4W Accn A new project was initiated in collaboration with the WHO towards the end of 2024. The C4W ACCT project aims to aims to strengthen capacity and support for national uptake of competency-based education in family planning (FP) and comprehensive abortion care (CAC) across five countries in Africa and Asia. It also seeks to build inter-professional collaboration International Federatlon of Gynecology and Obstetrlcs Trustees, report For the year ended 31 December 2024 among Ob-Gyns. midwives. and other key stakeholders to ensure sustainable improvements in women's health. Initially funded for a one-year period, the project is working with national member societies in Bangladesh. DRC. Mozambique. Nepal and Sierra Leone. With funding starting in October, the main focus in 2024 was on-boarding these five societies, with work on the main project deliverables (Needs Assessments. Road maps and Curricula assessments) commencing from January 2025. Fistula Surgery Training Initiative (FSTI) Funders: Texas Children's H05Pltal (TCH). an anonymous foundation and Hamlin Fistula Australia FIGO plays a crucial role in maternal and new-born health by addressing obstetric fistula, a life- shattering birth injury caused by unrelieved obstructed labour. It affectsthe most disadvantaged women in low-resource settings and leads to chronic leakage of urine and/or faecal matter. Without a trained, competent fistula surgeon to repair the injury, a woman with an obstetric fistula will be incontinentfor the rest of her life, causing unimaginable suffering and stigmatisation, a5 well as calamitous social and economic consequences. Obstetric fistula can be prevented by making quality maternal health services available for all, especially emergency caesarean sections (C-sections). Yet, tragically, the condition continues to devastate the lives of 50.000 to l 00,000 women every year in 60 of the world's low-resource countries. This adds to the backlog of one to two million women still suffering with the condition, due to the lack of well-trained, competent fistula surgeons. Recognising obstetric fistula as a neglected public health issue and to bridge the global treatment gap. in 2012, FIGO launched an ambitious training programme to greatly increase the number of fistula surgeons. The programme builds the capacities of 'FIGO Fellows, trai nee fistula surgeons from fistula-affected countries - starting with initial training in a FIGO Certified Training Centre and subsequent coaching sessions by FIGO Trainers. The initiative has expanded substantially since its early days, and at 31 December 2024, there were 93 Fellows from 28 high-need countries in sub-saharan Africa and Asia being trained as fistula surgeons. as well as multiple fistula care teams who have also received FIGO training. Eight new Fellows joined the Programme in 2024. Fifteen other established Fellows received coaching sessions with FIGO Trainers to enhance their fistula repair skills. Some of these sessions took place in Fellows, own facilities. and others in training centres. In addition. two more 'live on-line training sessions. were organised in 2024, making a total of 13 so far. Facilitated by FIGO Trainers and focusing on a specific aspect of fistula surgery each time, these popular sessions allow direct discussion between the Fellows and trainers, and are always well attended. International Federatlon of Gynecology and Obstetrlcs Trustees, report For the year ended 31 December 2024 The FSTI achieved notable milestones in 2024 includingthe following: Expert Surgicalworkshop. Addis Ababa, February 2024 The purpose of the workshop was to share ideas and discu55 new, as well as less established approaches on how to treat ongoing urinary incontinence post vesicovaginal fistula repair, with the aim of reducing/curing the incontinence and thereby avoiding a urinary diversion when possible. 2. Annual Expert AdvisoryGroup (EAG) meeting in Eldoret, Kenya, August 2024 The annual two days EAG meeting took place at FIGO Training Centre. Gynocare- Women's and Fistula Hospital in Eldoret, Kenya in August and provided the opportunity to discuss Fellow progress and multi ple issues relating to the Trai ning Initiative. 3. Surgicalworkshops, Eldoret. Kenya, August 2024 Following the EAG meeting, the project team and the Trainers of the EAG stayed on to hold a three-day surgical workshop for Kenyan Fellows in collaboration with the Gynocare team. Working directly with the Trainers, and with three operating theatres running simultaneously, the Fellows were able to see new techniques in fistula repair surgery and to further develop their skills. Additionally, equipment supplier Tim Beacon from Medical Aid joined the workshop to review the FIGO fistula instrument sets used by the FIGO Training Initiative to continue modifying and improving the sets. according to surgeons, recommendations. 4. New Fistula Training Centre In line with the growing initiative and the increasing need for more training places, conversations commenced to accredit a new training centre in northern Tanzania. At the end of 2024. an Mou was drawn up which is due to be signed in 2025. 5. Publication of Good Practice Recommendations The paper "FIGO good proctice recommendations to Standardize the assessment of outcomes following vesicovaginal fistula surgew, was submitted to the International Journal of Gynecology and Obstetrics (IJGO) in late 2024 and has now been published as an open-access special article which will also be included in the IJGO'S February 202 5 edition. The project team is currently exploring options to have the article translated into French and Portuguese. 6. Quarterly Fistula Newsletters Three FSTI Newsletters were compiled in 2024 and distributed worldwide to stakeholders of the FSTI and the fistula community. The fourth newsletter for 2024 was released in very early 2025. 7. Programme Statistics atthe end of 2024 At the end of December 2024, there were 93 Fellows from 28 countries enrolled on the FSTI, who had collectively performed more than 24.000 fistula repairs worldwide. as well as thousands of associated procedures, including 4th degree perineal tears, ureteric re- implantations and ongoing incontinence procedures, thus transforming the lives of some of the most vulnerable and hardest to reach women on the planet. International Federatlon of Gynecology and Obstetrlcs Trustees, report For the year ended 31 December 2024 8. Funding After extensive efforts by the fistula team to fund raise for the FSTI in the past, in order to ensure its stability and longevity by having several funding partners, in 2024, the FSTI was receiving funds from the following three donors= l. Texas Children's Hospital ITCH) - 2024 was year 5 of a 5 year contract 2. An anonymous foundation 2024 was year 3 of a 3 year contract 3. Hamlin Fistula Australia - 2024 was year 2 of a 3 year contract Discussions with TCH and the anonymous foundation took place in late 2024 and early 202 5, to expend the funding for the FSTI beyond December 2024 with the following results: l .Texas Children's Hospital ITCH). Funding was renewed for 2025 but instead of a multi-year contract, funding will now be renewed annually. For 2025, $400,000 were secured. 2. An anonymous foundation. Funding was renewed in early 202 5 and $750,000 were awarded over three years. Accelerating Measurable Progress and Leveraging Investments for PostPartum Haemorrhage Impact (AMPLI-PPHI) FIGO is working in a consortium on a four year. UNITAID funded project. led by JHPIEGO and in partnership with PATH. Member Societies in four target countries. DRC. Guinea. Kenya and India, are working alongside their JHPIEGO and PATH counterparts to bring about an increase in the demand and adoption of three newly introduced drugs to tackle PPH treatment and management. This focusses on the use of TXA, Heat-stable Carbetocin and the self- administration of misoprostol. During 2024, the third year of the project, country teams have developed national networks of key stakeholders. working together to advocate for the safe introduction, training and implementation of these critical drugs into frontline practice. They have raised their voices through their societies. using national opportunities to build awareness and taking opportunities to build commitment to their adoption as best practice. The year saw the successful launch of 2 additional country team5. Zambia and Nigeria. who have joined the programme. All 6 Society teams have led the way in updating Emergency medicine lists, supporting the registration of supplies of the drugs as well as now developing appropriate pathways to their inclusion and wider adoption. Working alongside consortium partners. developing curriculums and implementing training in selected training facilities, they have united multi-stakeholder national networks to increase commitment to tackling PPH and opened pathways to ensure the drugs can be scaled up. As a key element of creating this pathway to scale up through this project. 13 additional societies have been connected in. The development of the 'exchange hubs. linked to each of the target countries has allowed project learning. country experiences and lessons learnt to be shared and scaled up more quickly to a wider number of countries and allowed more women to receive the best possible care. FIGO mernber societies have been connected, and they are now developing strong hubs where they can exchange and support one another. International Federatlon of Gynecology and Obstetrlcs Trustees, report For the year ended 31 December 2024 The FIGO Leadership Development Initiative: Removing barriers to access and effective coverage of maternal healthcare (LDI:REACH) This grant was awarded by the Bill and Melinda Gates Foundation in October 2022 and commenced on November Ist 2022. It runs until October 315t 2025. It supports national Obstetric and Gynaecologic Societies in six countries in their efforts to improve maternal health outcomes and meet the UN'S Sustainable Development Goal (SDG) 3, by addressing targeted clinical interventions and looking at the barriers to the effective coverage of those interventions. in terms of the implementation of best practices. The focus countries are Ethiopia, Kenya, Nigeria, Pakistan, India (Uttar Pradesh and Bihar regions) and Bangladesh. The programme focuses on increasing the coverage of key maternal health clinical interventions. identifying the barriers to effective coverage of those interventions, locally. nationally and internationally and strengthening the professional society to address those barriers through four key approaches. These approaches focus on leadership empowerment, advocacy. gender equity and communication. Identification of barriers is informed by a bespoke Barrier Assessment Tool (BAT). which is conducted at national, regional and facility levels, every 4-6 months, with the aim to assess the specific context for each clinical intervention. Barriers are prioritised and tracked using a Barrier Tracker and the BAT is then repeated to monitor progress and developments. Strengthening the leadership skills and voice of the health professionals, and having a better understanding of why a particular recommended practice is not widely adopted is the key to removing the barrier and improving the provision of quality care. During 2024, country teams have undertaken 2 further BAT cycles. prioritised further key areas of focus to address those barriers and led training, developed job aids and updated national policies. A second 5 week leadership empowerment series was run by FIGO to continue to support professional society leadership skill development and a full year's. data on the effective coverage of best practices was collected, analysed and utilised for further learning. LDI.'REACH allows physicians to assess barriers to care, improve gender diversity, educate and collaborate on guideline implementation. collaborate with health care professionals and lead facility changes so that staffing, equipment and medications are available and all women can receive the right care for every birth. Ellmlnatlng CeNlcal Cancer Four pilot projects were funded by FIGO from dormant funds that were re-designated early in 2021. These projects are located in India. Nigeria. Columbia and Nepal and of the total funding of £80.000. the remaining balance was £16.905 as at the end of 2024. International Federatlon of Gynecology and Obstetrlcs Trustees, report For the year ended 31 December 2024 Divisions and Committees FIGO'S scientific committees bring together global leaders in clinical practice, research, and education collaborating to drive fO￿ard our mission and strategic plan. FIGO'S committees play a pivotal role in promoting education and research implementation, using evidence-based approaches to address key women's health challenges worldwide. In December 2024 the Board of Trustees approved the President's proposal to establish five new FIGO committees and a new division-the Division of Well Woman Health Care. With this addition, FIGO now has a total of 21 scientific committees organized under four divisions. The committees are very active and produce regular webinars. publications. statements. and other key outputs such as e-learning courses and educational infographics. FIGO funds most expenses of committees from its unrestricted funds and seeks additional funding from donors for individual in itiatives where appropriate. FIGO Trading Company The Charity's wholly owned trading subsidiary. FIGO Trading Limited. operates commercial trading activities on behalf of the Charity, including organising and managing the biennial FIGO World Congress of Gynecology & Obstetrics. occasional regional events and publication of the official journal of FIGO, the 'lnternational Journal of Gynecology and Obstetrics, (IJGO). The company made a profit of £60,554 during the year to 31 December 2024 (2023: £1,081,935). The company made a gift of £60.554 (2023: £1 .081 .935) to the Charity in accordance with its Memorandum of Association. The International Journal of Gynecology & Obstetrics (UGO) The International Journal of Gynecology & Obstetrics (IJGO) is the official scientific journal of FIGO. It publishes trusted. peer-reviewed original research. reviews and brief communications in all areas of obstetrics and gynaecology, with focus on globally relevant aspects of care and under the auspices of an international Editorial Board. Publications during 2024 included 15 papers authored by FIGO'S expert committees. which have all seen strong levels of readership and engagement. The number of submissions to the journal continues to grow up by 23% in 2024 compared with 2023 as does the number of articles accepted and published up by 12% in 2024 compared with 2023. The Impact Factor (IF) represents how many times papers published in IJGO were cited in indexed scientific journals during a particular year. The 2023 IF (announced in June 2024) saw a moderate drop to 2.6, down from 3.8 (2022), in a pattern consistent with most journals in the field post-covid. International Federatlon of Gynecology and Obstetrlcs Trustees, report For the year ended 31 December 2024 Many articles are accessed by academic institutional subscribers. and a number of free access and open access articles are downloaded by a wider readership. Uptake of open access by authors seen a moderate percentage decline in 2024 to 29% (from 38% in 2023), although due to the overall increase in total number of articles published. open access has remained an area of revenue growth (increased open access revenue in part offsets the continuing steady decline in subscriptions revenue). Total readership of UGO increased by 15.6% in 2024. Education, Communication and Advocacrf Committee (ECAQ This committee is chaired by the Vice President. The committee's aim is to leverage the experience and expertise of the Regional Trustees to identify the specific needs of each FIGO region. The overarching role of the committee is to provide guidance that supports FIGO to develop appropriate region-specific educational and training activities to address these needs. including timely advocacy efforts as and when the opportunity arises. ECAC oversees the FIGO global webinar series and will guide future educational efforts, liaising with divisions and committees and FIGO HQ. Financial review The principal funding sources of the group were contribution income from Society Member associations of £441,280 (2023= £420,586), Journal income of £810,751 (2023= £847,632), restricted grants of £2.165.873 (2023: £2.836.221) The group has incurred expenditure of £2,706,472 (2023= £3,614,893) in respect of restricted fund projects during the year a5 shown in Note 18 to the accounts. The group's unrestricted expenditure for 2024 was £2.511.251 (2023: £5.486.868). The group's unrestricted surplus (before movements on investments and foreign exchange) for 2024 was a deficit of £1,048,993 (2023= surplus of £520,420) in this non-congress year. FIGO registered gains of £85,148 (2023= gains of £277,560) on its investment holdings. Income received from investments in 2024 amounted to £220,267 (2023: £280,442). Negative foreign exchange translation differences totalled £31,237 (2023.. 105ses of £302,035). The group's balance sheet is strong with a closing total unrestricted reserves of £6,114,205 (2023: £7.109.287) and healthy liquidity provided by cash balances of £3.707.856 (2023.. £4.911.687) and investment holdings of £3.188.007 (2023.. £3.102.859). Total funds carried forward as at 31 December 2023 were £8,895,872 (2023: £10,431,546). International Federatlon of Gynecology and Obstetrlcs Trustees, report For the year ended 31 December 2024 FIGO participates in a multi-employer pension scheme. At 31 December 2024. FIGO'S share in the plan's surplus amounted to £45,000 (2023: surplus of £70,000), however this has been capped at £nil as FIGO is unable to access the surplus to reduce contributions or obtain a refund. FIGO recorded an actuarial gain of £nil (2023= £nil) during the financial year. Further details on the pension scheme are provided in note 20 to the accounts. The Charity adopts a prudent financial policy that aims to ensure that all activities undertaken are efficiently managed in accordance with approved budgets and in accordance with good practice. All expenditure is monitored and payments processed through a system that endeavours to ensure that any possibility of error is minimised. Principal risks and uncertainties The trustees perform a review to identify the major risks to which the Charity is exposed on an annual basis and have established system5 and procedures to mitigate these risks. These risk5 include the possibility of adverse currency fluctuations. a reduction in third party grants and donations and an unexpected downturn in attendance at the organisation's biennial Congress. An Audit and Risk Committee was created in October 2021 that functioned separately from the Finance Committee that dealt with the overall management of the Finances. In December 2023 the Board of Trustees asked the Executive to look at combining the Finance Committee with the Audit and Risk Committee to produce a single committee with oversight of all Finance, Audit and Risk related matters. This was formally established in 2024. The risks identified above are managed through a diverse investment strategy. ensuring a professional and effective relationship with the donor community and consideration of alternative revenue streams. The risks associated with the biennial Congress are managed via the Congress Organising Committee which meets several times during the planning period to ensure the successful management of the event (including mitigation of associated risks). FIGO maintains several foreign currenoi bank accounts for activities taking place internationally which are funded from donor grants. Expenditure incurred overseas is paid from these foreign currency bank accounts. thereby minimising any currency exposure. The group's principal financial a55ets are bank balances. trade debtors and investments. The group's credit risk is primarily attributable to its trade debtors. Trade debtors are included in the financial statements net of provision for doubtful debts. There is no significant concentration of credit risks, with exposure spread over many parties. A regular review is performed of available fund5 to settle debts as they fall due and active management of the trade debtors and creditors balances to ensure sufficient working capital is available to the group. International Federatlon of Gynecology and Obstetrlcs Trustees, report For the year ended 31 December 2024 Fundraising FIGO has not engaged in public fundraising and has not used professional fundraisers or commercial participators. The charity nevertheless is committed to observing all relevant fundraising regulations and codes. There was no non-compliance of these regulations and codes and the charity received no complaints relating to its fundraising practice. FIGO HQ has been receiving advice from consultants with expertise in writing grant proposals in order to identify new sources of funding. Several major donors are moving to a new model where they donate money directly to the region and countries involved in the projects. Reserves policy and going concern The organisation aims to retain sufficient free reserves to ensure the continued efficient running of the core elements of the Charity. The level of free reserves at any time will be affected by the proximity of the FIGO World Congress of Gynecology and Obstetrics, which now takes place every two years. Profits from the Congress are used to replenish the level of free reserves, to be drawn on to fund core activities of the charity in years when a Congress does not occur. The trustees consider that a baseline of free rese￿e5 should be maintained to ensure the core functions can continue for two years even in the event that a Congress is not profitable or has to be cancelled and uninsurable losses arise. Therefore, the level of reserves will fluctuate year on year but may represent up to two years, core operating costs lincluding Payroll. Rent and Information Technology). Based on current and planned levels of expenditure the level of reserve5 should vary between £2.Om and £4.0m. reducing as a Congress year approaches and depending on the result arising from the Congress. The level of financial reserves is reviewed continually by the Chief Executive and annually by the wider Trustee Board as well as by the organisation's Audit & Finance Committee. At 31 December 2024. the group has reserves that are freely available for expending on charitable purposes of £5,108,590 (2023= £6,063,225). This has been calculated as General funds. equating to total reserve5. excluding restricted funds. Pensions reserve and Designated funds. which includes the value of tangible fixed assets held for use by the charity. The reserves at 31 December 2024 are above the level required by the reseprfes policy of £2.2m (i.e. two year's payroll and information technology costs). International Federatlon of Gynecology and Obstetrlcs Trustees, report For the year ended 31 December 2024 Plans for the future The Charity aims to continue it5 charitable activities for the promotion of the health and well- being of women and their children by improving the practice of obstetrics and gynaecology. As part of supporting an enabling environment for this focus. we will continue to champion women'5 and girls, reproductive and health right5 more widely. recognising the increasing attacks on these rights in many countries and the adverse impact of funding cut5. In December 2023 the Board of Trustees endorsed a plan to review the efficiency and effectiveness of each area of FIGO'S current operation and to increase collaboration and impact across the organisation. This review. and a programme of work to deliver change informed by it, is a core focus for FIGO in 2025 and beyond. In 2024 we undertook reviews of several parts of our operation. These included finance systems and capability, IT infrastructure, membership services, projects and programmes in LMICS, our publishing contract for the International Journal of Obstetrics and Gynaecology and decision- making and cost-control for FIGO Congress. During 2025 we will review our communications and advocacy systems and capability, and potential future models for our education work. In 2025 we will invest to strengthen our business development capacity with an emphasis on securing income to fund and expand our programmes and projects with our member societies and other partners in LMICS. We will also strengthen our capacity in advocacy and continue to strengthen collaborative partnerships with organisations whose goals and values align with FIGO'S Strategic priorities. Over this period. we will continue to increase the capacity of our member societies to help strengthen their voice nationally and support their role in disseminating knowledge and expertise from FIGO'S Scientific Committees. We will continue our working relationship as Non- State Actors in Official Relations with the World Health Organisation, with a particular focus on reducing Post-Partum Haemorrhage. eliminating cervical cancer. and supporting access to family planning and comprehensive abortion care. In October 2025 we will stage our bi-annual World Congress in Cape Town. South Africa. Structure. governance and management The organisation is a charitable company limited by guarantee. incorporated on 4th July 2005 and registered as a charity on 14th March 2006. The company was established under a memorandum of association, which established the objects and powers of the charitable company and is governed under its articles of association. During 2019 the Articles of Association were rewritten and adopted at an Extraordinary General Meeting held in Manila, Philippines on Tuesday 12th November 2019. The Articles of International Federatlon of Gynecology and Obstetrlcs Trustees, report For the year ended 31 December 2024 Association were further amended by special resolution at a General Meeting of the Company held on Sunday 6th December 2020. All trustees give their time voluntarily and receive no benefits from the charity. Any expenses reclaimed from the charity are set out in note 6 to the accounts. Appointment of trustees The International Federation of Gynecology and Obstetrics has a single management body, the Board of Trustees. elected by it5 Society Members at each General Assembly meeting. Trustee induction and training New trustees receive detailed guidance on the organisational and decision-making structure of the organisation as part of their first meeting together with information on their legal and moral obligations as trustees of the charity. Trustees are also given a Trustee Handbook which outlines the way in which FIGO operates and includes detailed guidance on their role as a Trustee, their statutory duties and their responsibilities. In addition, they are required to sign a Code of Conduct. Trustees regularly consider the latest guidance from the Charity Commission and other relevant bodies on good practice and undertake such training as is recommended to them. Related parties and relationships with other organisations The trustees of the charity give their time freely and receive no remuneration other than reimbursement of reasonable out-of-pocket expenses. The Charity's wholly owned subsidiary. FIGO Trading Limited. was established to operate the commercial trading activities of the Charity and in each year of operation FIGO Trading Limited gifts its profits to the Charity. The Charity has a close relationship with The FIGO Charitable Foundation, a corporation incorporated in the State of Illinois. USA. The Corporation was established for charitable. educational and scientific purposes and during the year to 31 December 2023 its activity has been to raise funds for such purposes on behalf of the Charity. The FIGO charitable foundation receives Donor gifts denominated in shares and sells those shares for cash. which is then remitted to the Charity. During the year, £nil (2023= nil) was remitted for the project relating to Advocating Safe Abortion. The Charity also has a relationship with the International Federation of Gynecology and Obstetrics. which was established in Switzerland in accordance with Section 60 of the Swiss Civil Code et seq. On l January 2008, the Swiss organisation transferred its assets and activities International Federatlon of Gynecology and Obstetrlcs Trustees, report For the year ended 31 December 2024 to the Charity via a deed of gift. The Swiss organisation ceased all activity at that date and is now dormant. Remuneration policy for key management personnel The pay and remuneration of the charity's key management personnel is established through job evaluation, sector benchmarking, availability of funding, recruitment advertising, individuals, skills. knowledge & experience and relevant salary surveys comparison. The Chief Executive, together with Senior Managers, will review budget availability for all appointments. The President of FIGO reviews the remuneration of the Chief Executive and reports on this to the Board of Trustees. Statement of responsibilities of the trustees The trustees (who are also directors of the International Federation of Gynecology & Obstetrics for the purposes of company law) are responsible for preparing the trustees, annual report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Company law requires the trustees to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources. including the income and expenditure. of the charitable company for that period. In preparing these financial statements, the trustees are required to.. Select suitable accounting policies and then apply them consistently Observe the methods and principles in the Charities SORP Make judgements and estimates that are reasonable and prudent State whether applicable UK Accounting Standards and statements of recommended practice have been followed. subject to any material departures disclosed and explained in the financial statements Prepare the financial statements on the going concern basis unless it 15 inappropriate to presume that the charity will continue in operation The trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. In so far as the trustees are aware= There is no relevant audit information of which the charitable company's auditor is unaware The trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditor is aware of that information International Federatlon of Gynecology and Obstetrlcs Trustees, report For the year ended 31 December 2024 The trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company's website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions. The trustees, annual report. prepared in accordance with small company exemptions. has been approved by the trustees on 16 September 2025 and signed on their behalf by.. Dr Anne Beatrice Kihara President Independent auditor's report To the members of International Federation of G￿e(ologY and Obstetrics Opinion We have audited the financial Statements of International Federation of Gynecology and Obstetrics (the 'parent charitable company.) and its subsidiaries (the 'group') for the year ended 31 December 2024 which comprise the consolidated statement of financial activities, the group and parent charitable company balance sheets. the consolidated statement of cash flows and the notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The FinancialReportingStandard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice). In our opinion. the financial statements= Give a true and fair view of the state of the group's and of the parent charitable company's affairs as at 31 December 2024 and of the group's incoming resources and application of resources. including its income and expenditure. for the year then ended Have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice Have been prepared in accordance with the requirements of the Companies Act 2006 and the Charities Act 2011 Basis for opinion We conducted our audit in accordance with International Standards on Auditing (UK) (ISAS (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the group financial statements section of our report. We are independent of the group and parent charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK. including the FRC'S Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Conclusion5 relating to going concern In auditing the financial statements, we have concluded that the trustees, use of the going concern basis of accounting in the preparation of the financial statements is appropriate. Based on the work we have performed. we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charity's ability to continue a5 a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the trustee5 Wlth respect to going concern are described in the relevant sections of this report. Independent auditor's report To the members of International Federation of G￿e(ologY and Obstetrics Other Information The other information comprises the information included in the trustees, annual report other than the group financial statements and our auditor's report thereon. The trustees are responsible for the other information contained within the annual report. Our opinion on the group financial statements does not cover the other information. and. except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and. in doing so. consider whether the other information is materially inconsistent with the group financial statements or our knowledge obtained in the course of the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements. we are required to determine whether this gives rise to a material misstatement in the group financial statements themselves. If. based on the work we have performed. we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard. Opinions on other matters prescribed by the Companies Act 2006 In our opinion, based on the work undertaken in the course of the audit: The information given in the trustees, annual report for the financial year for which the financial statements are prepared is consistent with the financial statements The trustees, annual report has been prepared in accordance with applicable legal requirements Matters on which we are required to report by exception In the light of the knowledge and understanding of the group and the parent charitable company and their environment obtained in the course of the audit, we have not identified material misstatements in the trustees, annual report. We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 and Charities Act 2011 requires us to report to you if. in our opinion.. Adequate accounting records have not been kept by the parent charitable company, or returns adequate for our audit have not been received from branches not visited by us- or The parent charitable company financial statements are not in agreement with the accounting records and returns., or Certain disclosures of trustees, remuneration specified by law are not made- or We have not received all the information and explanations we require for our audit., or The directors were not entitled to prepare the financial statements in accordance with the small companies regime and take advantage of the small companies. exemptions in preparing the trustees, annual report and from the requirement to prepare a strategic report. 20 Independent auditor's report To the members of International Federation of G￿e(ologY and Obstetrics Responsibilities of trustees As explained more fully in the statement of trustees. responsibilities set out in the trustees, annual report, the trustees (who are also the directors of the parent charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view. and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement. whether due to fraud or error. In preparing the financial statements, the trustees are responsible for assessing the group's and the parent charitable company's ability to continue as a going concern. disclosing. as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the group or the parent charitable company or to cease operations, or have no realistic alternative but to do so. Auditor's responsibilities for the audit of the financial statements We have been appointed auditor under the Companies Act 2006 and section 151 of the Charites Act 2011 and report in accordance with those Acts. Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance. but is not a guarantee that an audit conducted in accordance with ISAS (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if. individually or in the aggregate. they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities. including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud are set out below. Capability of the audit in detecting irregularities In identifying and assessing risks of material misstatement in respect of irregularities. including fraud and non-compliance with laws and regulations, our procedures included the following.. We enquired of management and trustees. which included obtaining and reviewing supporting documentation, concerning the group's policies and procedures relating to.. Identifying. evaluating. and complying with law5 and regulations and whether they were aware of any instances of non-compliance. Detecting and responding to the risks of fraud and whether they have knowledge of any actual. suspected. or alleged fraud- Independent auditor's report To the members of International Federation of G￿e(ologY and Obstetrics The internal controls established to mitigate risks related to fraud or non-compliance with laws and regulations. We inspected the minutes of meetings of those charged with governance. We obtained an understanding of the legal and regulatory framework that the group operates in, focusing on those laws and regulations that had a material effect on the financial statements or that had a fundamental effect on the operations of the group from our professional and sector experience. We communicated applicable law5 and regulations throughout the audit team and remained alert to any indications of non-compliance throughout the audit. We reviewed any reports made to regulators. We reviewed the financial statement disclosures and tested these to supporting documentation to assess compliance with applicable laws and regulations. We performed analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud. In addressing the risk of fraud through management override of controls, we tested the appropriateness of journal entries and other adjustments. assessed whether the judgements made in making accounting estimates are indicative of a potential bias and tested significant transactions that are unusual or those outside the normal course of business. Because of the inherent limitations of an audit. there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk 15 also greater regarding irregularities occurring due to fraud rather than error. as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation. A further description of our responsibilities is available on the Financial Reporting Council's website at" www.frc.or auditorsres onsibilities. This description forms part of our auditor's report. Use of our report This report is made solely to the charitable company'5 members as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006 and section 144 of the Charities Act 2011 and regulations made under section 154 of that Act. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an auditor's report and for no other purpose. 22 Independent auditor's report To the members of International Federation of G￿e(ologY and Obstetrics To the fullest extent permitted by law. we do not accept or assume responsibility to anyone other than the charitable company and the charitable company's members as a body, for our audit work. for this report. or for the opinions we have formed. Joanna Pittman (Senior statutory auditor) 22 September 2025 for and on behalf of Sayer Vincent LLP. Statutory Auditor I l O Golden Lane, LONDON. ECIY OTG Sayer Vincent LLP is eligible to act as auditor in terms of section 1212 of the Companies Act 2006 23 Imernatlonal Federauon ol Gynecology and Obsteirlcs Consolldated siatemeni of Ilnanclal actlvrtles lincorporaring an income and expendiiure accounii For theyear ended 31 December 2024 2024 2023 Unrestricted Restricted Total Unrestrirted Restricted Total Note Income from.. Donations and legacies Charitable 8Ctivities Membership Projects World Congress journal Investmenis 7.486 46.988 46.988 441.280 441.280 2.165.873 117.5251 810.751 220.267 420.586 420.586 2.836,221 4,411.640 847.632 280.442 2.165.873 2.836,221 117,5251 810.751 220.267 4.411.640 847.632 280.442 Total Income 1.462.259 2.165.873 3.628,132 6.007.288 2.836.221 8.843,509 Expendilure on: Raising funds Charitable activilies 2.511.252 2.706.472 5.217.724 5.486.868 3.614,893 9.101,761 Total expenditure 3a 2￿11.252 2.706.472 5.217,724 5.486.868 3.614.893 9.101,761 Net income I lexpenditurel before net gains I Ilosse51 on investments 11.048.993) 1540.5991 11.589.592) 520.420 1778,6721 1258,2521 Net gains / (losses on investments) li 85,148 85.148 277.560 277.560 Net income I lexpenditurel ft>rthe year 1963.8451 1540.5991 11.504.444) 797.980 1778.6721 19,308 Transfers between funds Net income I lexpenditurel before other recognised gains and losses 19&3.8451 1540.5991 11.504.4441 797.980 1778.6721 19,308 Other gainsl Ilossesl on foreign exchange 131.2371 131.2371 1302.0351 1302.0351 Net movement In funds 1995.082} 1540.5991 {1.535.6811 495.945 1778.6721 1282.7271 Reconclllatlon of funds: Totalfunds broughtforward 7.109.287 3.322.259 10.431.546 6.613.342 4.100.931 10.714.273 Totalfunds carried forward 6,114,205 2,781,660 8,895,865 7,109,287 3,322,259 10,431,546 All of the above results are derived from continuing activities. Thereweie no other recognised gains or losses other than those staled above. Movements in funds are disclosed in Note 18 to the financial statements 24 International Federation of Gynecology and Obsieirics Balance sheets Company no. 05498067 As at31 December2024 Thegroup 2024 The charity 2024 2023 2023 Note FIKeiJ assets: Tangible assets Investments io 1.005,617 3.188,007 4.193,624 1,046,062 3,102,859 4.148.921 1.004.630 3.188,007 4.192,637 1,044,734 3,102,859 4,147,593 li Current a55ets: Debtors Cash at bank and in hand 14 1.414.916 3.707,856 5.122.772 2.159,001 4,911,687 7,070.688 2.181,821 2,887,381 5.069,202 2,903,419 4,059,430 6,962,849 Llabllltles Creditors.. amounts falling due within one year 15 1420,5311 1788.0631 1365.9741 1678,8961 Net current assets 4.702,241 6.282.625 4.703.228 6.283.953 Net asset5 excludingpension scheme liabiknty 8￿95.885 10.431.546 8.895.865 10.431.548 Defined benefit pension scherne surplu5 1 Iliabilityl 21 Total net a55ets 17a 8WS,865 10.431.546 8,895,885 10.431.546 Funds: Restricted income funds.. 2.781.660 3,322.259 2,781,660 3,322,259 Unrestricted income funds= Designated funds Generalfunds 1.005.617 5.108.588 I,IM6,062 6.lJ63.225 1,004,630 5.109,575 1,044,734 6.064,553 Pension reserve Total unrestricted funds 6.114.205 7,109.287 6.114,205 7.109,287 Totalfunds 8.895,865 10,431,546 8.895,865 10,431,546 Approved bythe trustees on 16th September 2025 and signed on their behalf by Dr Anne Kihara Dr Shanlha Kumaii President Treasure 25 International Federalion of Gynecoiogy and Obstelrics Consolldated statemenl of cash flows Fortheyearended 31 December2024 Note 2024 2023 Cash flowsfrom operallngactlvltles Net incomelexpenditure for the reporting period las per the statement of financial activities) Revaluation due to exchange rate movements Depreciation charges (Gainslllosses on investments Dividends, interest and rent from investments Decreasellincreasel in debtors Decrease in creditors (Decrease} in pension liability 11.535.681) 1282,7271 31,237 47,849 {85.1481 {220,2671 744,085 {367.5331 302,035 49,275 1277,5601 1280,4421 11,649,376) 168,591 Net cash provided by {used inl operating activities (1.385.459) 11,970,204) Cash flowsfrom investingactivities". Dividends, interest and rent from investments Purchase of fixed assets Proceeds from sale of investments 220,267 {7.4001 280,442 112.1141 Purchase of investments 17411 Net cash (used In) I provlded by Investlng actlvltles 212,867 267,587 Change in cash and cash equivalents in theyear (1.172.592) 11,702,617) Cash and cash equivalents at the beginning of the year 4.911.687 6.916,339 Change in cash and cash equivalents due to exchange rate movements 131,237) 1302,0351 Cash and cash equivalents atthe end of the year 3,707.856 4,911,687 26 IntefnaJonaIFedeialonotGyn￿Ql0gIan￿oh$Ieth Notestothettnan¢lalststements Fortheyeare￿edjJDe¢WDher2024 Atcoumtlngpollcles al Statutory InfomiatltsTh International Fedeiation of GYneCo￿8y£nd Obstetncs Lsachalrta￿ecOnW￿y￿ffllted byguarantee and 15 incorwxated lntheunrted￿￿ooTh. The registered officeaddress isSuite3.WatetiooCourt. IOTheedStreet. London. SE1￿. bl Baslsof preparatlon Thehnancialstatemems havebeen prepared in acCordancev￿thAccOuntIngandRe￿rtlngbycharIbeS-. StatementotRecommended praCt￿eappl￿ablet0cha[1tieS preparin¥theiraccountsinaccordance Ihthe Financial Reportingstandard appbcable in the UKand Republicof Ireland IFRS 1021- (cham￿sS0RPFRs l021.TheFinancialRek￿1￿%s1a￿dard aPP￿CabIe IntheUK and Republicotlreiand IFRS 1021 and IheCompaniesAct2006. Assets and babibtiesare InIt￿llyreC01nised 3thist0ncalcostortransact￿V3bjeU￿esS0ther￿i$e ststed inthe lelv4antaccountingr￿"cy0rn0Ie. These linancialstatementsconsoiidatethe resuitsofthec￿rl1abieC0mPanYand itS*tho1ty-th￿d Subsidiary￿GOTT2din8 ￿m[[ed Icompanyregistration number05PS59051 ona lineby line basis. Transactions and balances between thecharitablecompanyand itSSUtHdiaryhavebeenebminatedftomtheconsobdatedfinanck41siatemenis. BaIanceSbe￿eenIhe￿o companies are disclosed inthe notesofthe charitsblecompanys balance sheet.AseparatesiatemenioffinancialactMDe&orincomeandexpendrtuieaccouM,foithe charrtaNe companyitself is notpresented becausethechaiiiabLe company hastaken advaMageoftheexemptyons3fforded bysection408ofthe CornpanlesAct2￿￿. In applYlnEthefinanclalrepo￿ngfYameWttlk.Ihe tYusteeshavÈmadeanumberofsubJectwejudgements.forexaMp￿In iespectofsgnilicaniaccountingestimates. Estimatesandiudgementsaye cantlnuallyevaluated andare based on histaricalexpeyienceand otherlattors. IncludingexK*CtationstslluluieeventSlhaiate bÈlievedtobereasonableundeithÈ circumsiances. The nature olthe esiimation mÈansthÈ 3ttualouttom￿C0uLd differliomthole èstimates.Any*gnificantestimatesandjudgemÈntsaffectingthesefinancialstatementsate dÈtaiiedwithin the rÈlevaniactoUntingpo￿cY below. cl Public benefftenity ThecharilableGDmp3ny meetslhedelinitiDnola publK benefit EntttyundeiFRS I¢Y2. dl Goingconcern ThelrusteescoDsiderthaltheieare no malenal unEertainlie5aboulthe£fvatrt8lAec(wnpatrfsatslitylocDnbnuEa5agDingconccwn. IliseFFectedthatina DDn-COnEre55year. FlGOmayoperatE￿lh￿ small unreslricled delicil and a150 h45 suthcienllreE ie5EryeSloen5ureconlinuedeffK￿n1IvTrning0f IhEcoieelemen150f IheCharity- Thetrusteesdonol considerthattheieareanysource5otestimationuncertaintyatthewe￿￿tinKdate1hatknaVeaSlgn￿cantriSkofcausin¥a materialadju5trnenttothe ca￿￿￿gam0Unts Df a55etsand abilitreswithin the nextreporknngperiod. el Income Income Is recognisedwttenthe chadtyhas endttÈmenttothefunds. anyperformanceconditionsattathedtothe IKomÈha¥e been met.lt Iswobabiethatthe Incomewllbetecelvedandthatthe amount can bemeasured Yebably. IncornE Irorn govemmEntaDd olhergranls. whelhEF'rapit41'gr¥n15Dr'revETw'giants. isrK(gn15Ed*fienlheCh4tityfva$￿tiI1c1nentlQ1hPlU￿d$. atyPErfotmtn¢eGonditioD54llarhedtolhegrantshave been tTret. itis probablethatthe incomewllbereceivedaDdthearnountcaD betne35ur£d relKit4yand 15DoI Oeletred. FIGOSociety MembeiAffiliateMernbershipleesareaccountedtoronanaccwua15ba5i%. Incornefrorn royaltiesand edrtonalsupportlUGOI Isreco8nised*thenthechatityhasem￿ement[OthefUnd5. itisprobabieihattheinc0￿eWrtl be recewed andthe amount can be measuied reliably. Congress Incomeis recognisedas 1ncomeintheyearthatthec￿gle55￿keS￿ace.cOngIesSInc￿ne receNed inadvaKeisdeferwed untilU*yearof thecongress. Incorne recewed in advanceofthe prowsionota specThedserwce Isdefetredu￿￿thecriteriaf0rI￿comereco8nMOnare met. fl Inte￿st Yecelvable Intereston funds held ondeposrtl5includedwhenrece￿ab1e andthearnoUntCa￿ bemeasuwed rebabiytythecharitr.this ￿norI￿allYupO￿notiThCa￿on of the interestpaid orpayablebythe bank. gl Fund aE¢ouTrting Restrictedfunds areto be used forspecific purrKJsesasiaid drf*ntythe donor. Expenditurethichmeetsthesecriteriaischargedtothefund. Uniestrictedfundsayedonationsand otherincomingresourcesreceNedorgeneratedforthe charTtabiewrposes. Designatedfundsare unrestncted lundsearrnarkedbythetrusteesfor parDcuiarpurp)ses. 27 IntefnaJonaIFedeialonotGyn￿Ql0gIan￿oh$Ieth Notestothettnan¢lalststements Fortheyeare￿edjJDe¢WDher2024 Ar¢ountingpoliciesl¢ontiTruedl h) Expendltuieand lYreco¥ernbleVAT Expenditure is recognisedoncelhereis a legalorconslwctwe obligaliontomakeapayThenttoalhirdparty. it￿probableknatSetUeThent￿ubereqU1[ed andtheatnountof theobligation can bemeasure reliably. Expenditure isclassrfied underthefollowingactmtyheadings.- Costs of raisingfundsreiatetothe costsassouated*Tth altr￿ngd0na1￿jnsandin¥estMW[ma￿agemeThtc0Sts. Expenditureon charitable actNities includesthec0stsofdeb¥eringitsacthTDesa￿ ser¥icesforffs beneficiaries. In includesbothcoststhaicanbe allocaieddirectlyto such aCti￿lies3￿d those costs of an indirectnature necessaryto supportthem. Otherexpendlture Yepyesentsthoseitemsnotfallingintoanyother t*ading Support costs are ihoselunctlons 1P￿t￿SSi51the￿0lk￿fthÈtharNyh￿1d0notdIieCIlyunéertake£harrta￿Ae3CNtes. SuprM)rtcDstslncludestaffcDsts.flnance costsand governance cosisthat supptsrtthe chaYity'SaCtiwties.ThÈsetosts have bÈenallotatedto eXper￿lI￿re¢lrt chantsbleactmth￿cOSIS ie&tingto apartlCulaiactNityareaUocated direttlyand Oihersare apportltsned IrYÈcoveYableVATiSthaYgedas a tost3EalnsttheactMtyfor¥thichtheexpÈndrturewaskicurred_ il Grants payable Giants payèbleaie madeto thlrd partles In furtherance of thecharWsoblect& Sm&ÈormU￿￿YÈarEr3ntsarÈatcounlÈrtrol1yhen ertheithe Yecipiemhas a ieasonabie expectationthattheywlllreceive a grant and thetrustees haveagreedt0paylhegrzntwithoutcondition.oi therecip￿rnthaS3lÈ3$0na￿￿ee￿￿￿3￿Offt ihattheyvthUreteNe a grant and Ihatanycondrtitrn allachingiothe giani Isouisideofthe control of thecharlty. PrDwsionsfDrgrantsare madewhenthe intEnliontotDakeagianlha5 bEenc(wnmuDKaledlothErewpEnl bullhere LSUllCCrtaintyatsou1￿the[IheII1DingVI IhegrantorlheamDuntotgiantpayable. 11 Tangiblefixed assets Ilern50f Equipmenlare capila115ed wheielhe pur¢ha5epnceeKeeds£L.50D. Deprecialion£o4sarEaliocaledtoaclMlie5on lheba5150fthEu5eottk￿ ielaled a55elsinlhose aclwities.Assetsare reviewEdfTri Impaiitnenl Ilciicumsl4n¢£sindiEalelheircatTrinÉvaluemayexceedthwwnelreabsabievalueandvalue iDuse. MajoriorDpoDent5aretrealeda5 a separate asselwhere Iheyhave signrficantly different pattErnsolcon5UrnPtion oleGDnomic ￿t￿tsand￿re1£￿eC1attd 5eparateiyobYri15uselul bre_ Wherefixed assetshave been revalued.anyexcessbetweentherevaluedamountandlhe h￿0￿cC0s1of theaSSet￿l1b&Sho￿asa revaluation re5eNe inthe balancesheet. Depfeciation is provided atrate5calcuiatedtowtttedownihecostoteacha5setto itse*imated re5KJualvalueoveiTtsexpected u5efuliTFe.Thedepreciation rates In useare asfDIIows-. Long leasehold pYoperDJ Leasehold Improvements OthceequiprnEnt Compulei equipmetrt Not